The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
about
The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's diseasePotential future neuroprotective therapies for neurodegenerative disorders and stroke.Cognitive follow up of a small cohort of Huntington's disease patients over a 5 year periodCell therapy in Huntington's disease.Novel therapeutic targets for Huntington's disease.Korean Red Ginseng Extract Attenuates 3-Nitropropionic Acid-Induced Huntington's-Like SymptomsEffects of Panax ginseng in Neurodegenerative Diseases.A pilot assessment of parental practices and attitudes regarding risk disclosure and clinical research involving children in Huntington disease families.Emerging drug therapies in Huntington's disease.Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences.Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington's disease in rats.Protective Effect of Spermidine Against Excitotoxic Neuronal Death Induced by Quinolinic Acid in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism.Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington's disease in rats.BDNF and extracellular matrix regulate differentiation of mice neurosphere-derived cells into a GABAergic neuronal phenotype.Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice.Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease
P2860
Q28705237-37832932-F435-4951-8744-57F43A17A060Q33687436-FE8410A1-EDA3-4D6B-A04C-ACA3AB5ED3A3Q33704993-6EC2FC4B-6B65-4FFE-A98E-FD6212206258Q36045364-ADFE5DAE-F30E-4812-9B03-1DE9901C4F70Q36219680-1CD62BF2-D5D6-461A-B938-C22B5C45A7A2Q36599891-793519A8-ABD5-4176-A93B-BD20C9985E8EQ36861205-C43C7916-B689-4344-A215-F7C66602BBEBQ37002400-7DC14E5C-B924-4CA7-A9D7-763F82416A1CQ37488273-806C0AF1-AB3B-4FAD-B3E0-0049676886A6Q40231756-8FF0F739-363F-43BB-9783-68E92805C93BQ41680012-F6F00C3C-D34A-4492-B75C-FDA374708994Q45288635-7F8B322B-06C6-4C6F-8AC3-1B2AB4603CCEQ45292792-94A70182-E7AC-4880-B107-BD14F317DE7EQ46097503-E6FCD72F-9FCC-44CF-BC0D-80E411015C42Q48562910-63418CA4-A8B1-4928-A6BE-7D08456BF60EQ52147068-995F98D0-8AB7-4BBC-A232-CE930E29E14AQ58691859-5FE94E14-B7E1-463C-9D5E-79C801E72A8E
P2860
The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
@ast
The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
@en
type
label
The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
@ast
The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
@en
prefLabel
The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
@ast
The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
@en
P2860
P356
P1433
P1476
The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
@en
P2093
Jang-Ho J Cha
Julie Leegwater-Kim
P2860
P304
P356
10.1602/NEURORX.1.1.128
P577
2004-01-01T00:00:00Z